Firstly 65% of this quarters expense is on Research and Development, and this is a good thing.
Money is well managed and put to best use.
Ongoing projects seems to be taking longer than expected, or are they?
Do we really know what's involved?
What we are not seeing in this update is behind the scenes bigger picture, and I am convinced they have their hands tied on what they can say publicly. We know they are talking to the big players and until all the i's are dotted and the t's crossed, we will be bound to confidentiality agreements.
It came across a bit bland and could probably have been better worded, to maybe reassure and encourage shareholders, Information in this quarterly is already common knowledge, other than the new commercialisation Director.
Our biggest shareholder spent big on those 14c options, he won't be throwing good money after bad.
Lets also not forget that for confidentiality reasons, we still don't know who took the other 10 million options.
When the deals are announced, it should become obvious.
PSY Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
